from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0206c/mmpL3

LFCtreatmentdescriptionclass of inhibitor

-1.224

Amikacinug/mL Amikacintranslation

-1.619

Cap5-10ug/mL Capreomycintranslation

-2.245

Rox10-50 ug/mL Roxithromycintranslation

-0.035

SM2-5 ug/mL Streptomycintranslation

-0.997

Tet5-10 ug/mL Tetracyclinetranslation

-0.461

Rif0.2-5ug/mL Rifampicintranscription

-0.353

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.426

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.532

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.596

CPZ10-50 ug/mL Chlorpromazinerespiration

0.155

Clofazimine10-13 ug/mL Clofaziminerespiration

0.345

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.407

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.896

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.497

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.114

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.880

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.587

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.299

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.191

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.594

KCN5-20 ug/mL Potassium cyaniderespiration

-0.297

NaN30.2-2 mM Sodium aziderespiration

0.181

Nigericin50 uM Nigericinrespiration

-0.939

TRC10-150 ug/mL Triclosanrespiration

-1.101

TRZ10-25 ug/mL Thioridazinerespiration

-1.219

Valinomycin0.5-10 uM Valinomycinrespiration

0.750

ZnSO42 mM ZnSO4respiration

-0.079

menadione6-10 ug/mL Menadionerespiration

-0.087

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.233

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.024

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.422

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.987

NRP_1Non-replicating persistence stage 1dosRassociated

1.209

Amp0.2mg/mL AmpicillincellWall

0.922

Cephalexin20-100 ug/mL CephalexincellWall

0.639

Cerulenin0.32-5 ug/mL CerulenincellWall

0.166

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.845

EMB10-20 ug/mL EthambutolcellWall

1.592

Eta12-40 ug/mL EthionamidecellWall

2.291

INH0.2-0.4 ug/mL IsoniazidcellWall

1.309

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.021

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.331

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.987

BZA0.12 mg/mL BenzamidearomaticAmides

-0.339

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.039

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.504

H2O24 mM hydrogen peroxideDNAdamaging

0.428

Levo10 ug/mL LevofloxacinDNAdamaging

0.781

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.515

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.338

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.535

UVUV-irradiationDNAdamaging

-1.120

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.120

Antimycin12.5-50 ug/mL Antimycin A?

0.419

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.051

PA_110-50 ug/mL Antitubercular compound PA-1?

0.188

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.025

PA8240.2-2 ug/mL PA-824?

-0.366

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.006

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.514

Verapamil50 uM Verapamil?

0.134

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.054

methoxatin10-20 ug/mL Methoxatin?